BIOVERATIV INC's ticker is BIVV and the CUSIP is 09075E100. A total of 453 filers reported holding BIOVERATIV INC in Q2 2017. The put-call ratio across all filers is 1.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $2,730,000 | -81.3% | 50,640 | -80.2% | 0.01% | -83.6% |
Q3 2017 | $14,629,000 | -26.2% | 256,326 | -22.2% | 0.06% | -33.7% |
Q2 2017 | $19,814,000 | +13.1% | 329,286 | +2.4% | 0.09% | +15.0% |
Q1 2017 | $17,514,000 | – | 321,618 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthCor Management, L.P. | 5,000,000 | $272,300,000 | 12.49% |
Newtyn Management, LLC | 800,000 | $43,568,000 | 6.55% |
TERRIL BROTHERS, INC. | 280,902 | $15,298,000 | 5.40% |
SENZAR ASSET MANAGEMENT, LLC | 343,800 | $18,723,000 | 4.74% |
NAYA CAPITAL MANAGEMENT UK LTD | 466,641 | $25,413,000 | 4.66% |
ValueAct Holdings | 8,476,892 | $461,652,000 | 3.86% |
Sarissa Capital Management LP | 155,000 | $8,441,000 | 3.34% |
13D Management LLC | 129,296 | $7,041,000 | 2.76% |
Provident Investment Management, Inc. | 266,623 | $14,520,000 | 2.70% |
Camber Capital Management LP | 1,100,000 | $59,906,000 | 2.43% |